Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.01.2021 | Case report

Bevacizumab

Retinal vascular changes following an off-label treatment: 26 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Gonzalez A, et al. Fluorescein angiographic features post-intravitreal bevacizumab for retinopathy of prematurity: can they support rescue laser photocoagulation to the avascular retina. Canadian Journal of Ophthalmology 55: 373-381, No. 5, Oct 2020. Available from: URL: http://doi.org/10.1016/j.jcjo.2020.05.017 Gonzalez A, et al. Fluorescein angiographic features post-intravitreal bevacizumab for retinopathy of prematurity: can they support rescue laser photocoagulation to the avascular retina. Canadian Journal of Ophthalmology 55: 373-381, No. 5, Oct 2020. Available from: URL: http://​doi.​org/​10.​1016/​j.​jcjo.​2020.​05.​017
Metadaten
Titel
Bevacizumab
Retinal vascular changes following an off-label treatment: 26 case reports
Publikationsdatum
01.01.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-87992-7

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Prednisone

Case report

Acetylcysteine

Case report

Alendronic acid